Navigation Links
Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones
Date:5/5/2011

BEER-SHEVA, Israel, May 5, 2011 Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.

Bilenca's project is based on a standard camera cellphone and a red laser pointer that can noninvasively obtain finger blood perfusion images with excellent resolution and contrast in less of a second. It uses the principles of optical polarization/speckle and cellphone technology built into a portable probe that creates images that detect malaria pigment (hemozoin crystals) in blood as well as micro-obstructions in the circulatory system that result from the infection.

In contrast to commercially available malaria tests, this probe will avoid the need for blood collection, therefore maximizing medical safety, patient comfort and test rapidity. Malaria causes approximately 1 million deaths per year throughout developing countries (85 percent of which are children under five).

"Our diagnostic probe is portable, simple to use and inexpensive to produce," Bilenca explains. "This probe helps meet the need for diagnostic technologies capable of noninvasive, reliable and rapid diagnosis of malaria in resource-limited areas. If successful, it will aid in the patient triage at hospitals and also be of tremendous value in monitoring these patients in intensive care settings prompting aggressive treatment in severe malaria cases when necessary."

Bilenca received one of 88 grants awarded to explore bold and largely unproven ways to improve global health. The $100,000 grants have been awarded to researchers from 25 countries. This marks the sixth round of funding from Grand Challenges Explorations (GCE), an initiative designed to help lower the barriers for testing innovative ideas in global health. Projects selected for funding focused on polio eradication and vaccines, cellphone applications for global health, new approaches to cure HIV, sanitation technologies, and new ideas to improve the health of mothers and newborns. Winners were selected from more than 2,500 proposals and approximately 100 countries.

"GCE winners are expanding the pipeline of ideas to address serious global health and development challenges where creative thinking is most urgently needed. This effort is critical if we are to spur on new discoveries that ultimately could save millions more lives," said Chris Wilson, director of Global Health Discovery at the Bill & Melinda Gates Foundation.

Dr. Bilenca is a member of BGU's Department of Biomedical Engineering and the Ilse Katz Institute for Nanoscale Science and Technology, where he is establishing a state-of-the-art laboratory in the fields of biomedical and nano optics. He is collaborating with Dr. Linnie Golightly, M.D. at the Weill Cornell Medical College in New York.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Related medicine news :

1. Medical Surrogates May Pay Emotional Price for Crisis Decisions
2. New genomics research investigates metastatic childhood cancers
3. Victor Chang scientists unlock the gates on sudden cardiac death
4. NIH, Gates Foundation and Colorado State team up to find new approach to a TB vaccine
5. BUSM investigates cellular mechanisms leading to immune response in airway epithelium
6. UI study investigates variability in mens recall of sexual cues
7. Thesis investigates characteristics of society using sports activities as research tool
8. AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access
9. Drug mitigates toxic effects of radiation in mice
10. Georgia Tech awarded Gates Foundation grant for innovative global health research
11. Food Safety Law Firm Investigates Major Outbreak of E. coli Linked To Lettuce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC ... as the official title sponsor of the Baltimore Women’s Classic, the largest all women’s ... will walk or run the course around the Baltimore Inner Harbor. Mercy has been ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Library for documenting and diagramming network and data center assets and audio-video devices ... subscribers can request new equipment shapes for free and download shapes and stencils ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  The Global ... Japanese public-private partnership formed to battle infectious diseases ... totaling US$23 million* that could help deliver a ... of debilitating conditions. This latest ... Phase 3 clinical trial testing a pediatric formulation ...
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... 29, 2017  Glenmark Pharmaceuticals, a global pharmaceutical ... an investigational fixed-dose combination of mometasone furoate (25 ... as a nasal spray being studied for the ... from a recently completed Phase 3 trial assessing ... therapy versus mometasone, olopatadine or placebo. ...
Breaking Medicine Technology: